Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Divestments (2025)

Whitehawk Therapeutics (WHWK) has disclosed Divestments for 1 consecutive years, with -$70000.0 as the latest value for Q3 2025.

  • Quarterly Divestments changed N/A to -$70000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $101.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $101.3 million for FY2025, N/A changed from the prior year.
  • Divestments for Q3 2025 was -$70000.0 at Whitehawk Therapeutics, down from $101.4 million in the prior quarter.
  • The five-year high for Divestments was $101.4 million in Q1 2025, with the low at -$70000.0 in Q3 2025.